Skip to content
← Back to this collection

PUBLICATIONS · 33559396

Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2021 Apr
First author
Rau RE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Rau RE
      type
      Author
    2. name
      Dai Y
      type
      Author
    3. name
      Devidas M
      type
      Author
    4. name
      Rabin KR
      type
      Author
    5. name
      Zweidler-McKay P
      type
      Author
    6. name
      Angiolillo A
      type
      Author
    7. name
      Schore RJ
      type
      Author
    8. name
      Burke MJ
      type
      Author
    9. name
      Salzer WL
      type
      Author
    10. name
      Heerema NA
      type
      Author
    11. name
      Carroll AJ
      type
      Author
    12. name
      Winick NJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Rau RE
      type
      Author
    2. name
      Dai Y
      type
      Author
    3. name
      Devidas M
      type
      Author
    4. name
      Rabin KR
      type
      Author
    5. name
      Zweidler-McKay P
      type
      Author
    6. name
      Angiolillo A
      type
      Author
    7. name
      Schore RJ
      type
      Author
    8. name
      Burke MJ
      type
      Author
    9. name
      Salzer WL
      type
      Author
    10. name
      Heerema NA
      type
      Author
    11. name
      Carroll AJ
      type
      Author
    12. name
      Winick NJ
      type
      Author
    bibliography ids
    1. nci-bib-a5635243d1e775045d9be3f2
    book metadata
    content sha256
    2e77d34294915818ee359ee7b089008b425eec1a2b495982595a40492bacb3a5
    document type
    citation
    dois
    1. 10.1002/pbc.28929
    electronic publication date
    display
    2021 Feb 9
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33559396
    immutable id
    pubmed:33559396@2e77d34294915818ee359ee7b089008b425eec1a2b495982595a40492bacb3a5
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    4
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e28929
    volume
    68
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33559396
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      ed3499fa453346b0583d152325f469ad68930f58740d2ca73be545e967cdaa8a
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Apr
      precision
      month
      year
      2021
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33559396/
      title
      Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice